Madrigal Pharmaceuticals Inc
MDGL
Market Cap$6.54B
Close$
$151.95
47.8% downside
Current Fair Value
47.8% downsideOvervalued by 47.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.54 Billion |
|---|---|
| Enterprise Value | $6.36 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-21.9 |
| Beta | -0.92 |
| Outstanding Shares | 22,091,314 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -16.62 |
|---|---|
| PEG | -199.57 |
| Price to Sales | 145.48 |
| Price to Book Ratio | 9.09 |
| Enterprise Value to Revenue | 102.27 |
| Enterprise Value to EBIT | -11.83 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Madrigal Pharmaceuticals Inc
CEO: Rebecca Taub